The FY2024 (Dec) proxy of Viridian Therapeutics, Inc.\DE names 22 peer companies for pay. Pay versus performance data of Viridian Therapeutics, Inc.\DE for that year is not on file, so it has no rank.
Pay peer group, FY2024 (Dec) proxy
| Anaptysbio | ||
| Celldex Therapeutics | ||
| Immunovant | ||
| Arcus Biosciences | ||
| Keros Therapeutics | ||
| Kura Oncology | ||
| Arcutis Biotherapeutics | ||
| Aerovate Therapeutics | Not disclosed | Not disclosed |
| Akero Therapeutics | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals | Not disclosed | Not disclosed |
| Day One Biopharmaceuticals | Not disclosed | Not disclosed |
| KalVista Pharmaceuticals | Not disclosed | Not disclosed |
| Kiniksa Pharmaceuticals | Not disclosed | Not disclosed |
| Mersana Therapeutics | Not disclosed | Not disclosed |
| Morphic Holding | Not disclosed | Not disclosed |
| Pliant Therapeutics | Not disclosed | Not disclosed |
| Prothena | Not disclosed | Not disclosed |
| Replimune Group | Not disclosed | Not disclosed |
| Sutro Biopharma | Not disclosed | Not disclosed |
| Syndax Pharmaceuticals | Not disclosed | Not disclosed |
| Ventyx Biosciences | Not disclosed | Not disclosed |
| Viking Therapeutics | Not disclosed | Not disclosed |
22 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.